SPONSOR
H. Lee Moffitt Cancer Center and Research Institute
Total Trials
8
Recruiting
8
Phases
Phase 1, Phase 1, Phase 2, Phase 2
Conditions studied: HER2-positive Breast CancerPancreatic CancerSmoking CessationHIVBrain MetastasesHR+ Metastatic Breast CancerHigh Grade SarcomaOvarian CancerColorectal Cancer ScreeningHepatitis C Virus
NCT05378464 Phase 1
Recruiting
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
HER2-positive Breast Cancer
NCT06423963
Recruiting
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
Pancreatic Cancer
NCT05746442
Recruiting
Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS
Smoking Cessation
NCT04923542 Phase 1, Phase 2
Recruiting
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
Brain Metastases
NCT05301283 Phase 2
Recruiting
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
High Grade Sarcoma
NCT05316129 Phase 1
Recruiting
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Ovarian Cancer
NCT06745895
Recruiting
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
Colorectal Cancer Screening
NCT06409390 Phase 2
Recruiting
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Metastatic Breast Cancer